English
Advanced Enzyme Technologies Q4 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
267.95
-4.10 (-1.51%)
-4.10 (-1.51%)Volume3.27 K
Updated: Fri 23 Jan, 2026 | 15:20:37
NSE
268.40-3.55 (-1.31%)
-3.55 (-1.31%)Volume1.02 L
Updated: Fri 23 Jan, 2026 | 15:31:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Advanced Enzyme Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 131.65 | 122.83 | 7.18% | 126.85 | 3.78% |
| Depreciation/ Amortization | 10.08 | 8.97 | 12.28% | 9.28 | 8.61% |
| Operating Income | 35.53 | 46.28 | -23.24% | 30.96 | 14.74% |
| Net Income | 26.48 | 37.65 | -29.66% | 28.31 | -6.46% |
| Other Operating Expenses Total | 38.65 | 40.50 | -4.57% | 34.45 | 12.20% |
| Net Income Before Taxes | 43.46 | 53.02 | -18.03% | 39.61 | 9.72% |
| Total Revenue | 167.18 | 169.11 | -1.14% | 157.82 | 5.93% |
| Selling/ General/ Admin Expenses Total | 36.84 | 34.52 | 6.70% | 32.48 | 13.42% |
| Diluted Normalized EPS | 2.37 | 3.36 | -29.55% | 3.54 | -33.22% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.